Incyte
INCY
#1110
Rank
C$27.80 B
Marketcap
C$141.63
Share price
2.05%
Change (1 day)
34.82%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$2.31 Billion

According to Incyte's latest financial reports the company's total liabilities are C$2.31 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$2.86 B35.67%
2023-12-31C$2.11 B5.81%
2022-12-31C$1.99 B34.62%
2021-12-31C$1.48 B22.44%
2020-12-31C$1.21 B11.92%
2019-12-31C$1.08 B10.34%
2018-12-31C$0.98 B16.06%
2017-12-31C$0.84 B-48.43%
2016-12-31C$1.63 B41.22%
2015-12-31C$1.16 B13.84%
2014-12-31C$1.01 B16.36%
2013-12-31C$0.87 B74.26%
2012-12-31C$0.50 B-11.15%
2011-12-31C$0.56 B-2.14%
2010-12-31C$0.57 B-32.58%
2009-12-31C$0.85 B55.6%
2008-12-31C$0.55 B26.9%
2007-12-31C$0.43 B-14.96%
2006-12-31C$0.51 B11.44%
2005-12-31C$0.45 B-12.99%
2004-12-31C$0.52 B80.24%
2003-12-31C$0.29 B-25.93%
2002-12-31C$0.39 B-6.7%
2001-12-31C$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
C$111.24 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.72 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$125.83 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.44 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.45 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$86.39 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
C$0.10 B-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$0.19 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA